NEPHROS, INC. Amortization of Debt Issuance Costs
NEPHROS, INC. (NEPH) reported Amortization of Debt Issuance Costs of $142.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2015-04-15
- NEPHROS, INC. amortization of debt issuance costs for the quarter ending 2014-03-31 was $142.00K, a 30.39% decline year-over-year.
- NEPHROS, INC. amortization of debt issuance costs for the quarter ending 2013-03-31 was $204.00K.
- NEPHROS, INC. amortization of debt issuance costs for the quarter ending 2011-12-31 was $0.00.
- NEPHROS, INC. amortization of debt issuance costs for the quarter ending 2011-09-30 was $0.00.
- NEPHROS, INC. amortization of debt issuance costs for fiscal 2014 was $142.00K, a 64.41% decline from fiscal 2013.
- NEPHROS, INC. amortization of debt issuance costs for fiscal 2013 was $399.00K.
- NEPHROS, INC. amortization of debt issuance costs for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- NEPHROS, INC. amortization of debt issuance costs for fiscal 2011 was $40.00K, a 20.00% decline from fiscal 2010.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $142.00K 10-K · filed 2015-04-15 | ||||
| 2014-03-31 | $142.00K 10-Q · filed 2014-05-14 | ||||
| 2013-12-31 | $399.00K 10-K · filed 2015-04-15 | $257.00K 10-K · filed 2014-03-28 | |||
| 2013-03-31 | $204.00K 10-Q · filed 2014-05-14 | ||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-04 | $0.00 derived: sum of 2 quarters · filed 2013-03-04 | $0.00 derived: sum of 3 quarters · filed 2013-03-04 | $40.00K 10-K · filed 2013-03-04 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $40.00K 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $40.00K 10-Q · filed 2012-08-14 | |||
| 2011-03-31 | $40.00K 10-Q · filed 2012-05-15 | ||||
| 2010-12-31 | $50.00K 10-K · filed 2012-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |